The new treatment that could change the lives of children with peanut allergies

peanut allergies

The new treatment that could change the lives of children with peanut allergies

Ask any parent what they want for their child, and they’ll likely tell you the exact same thing. All they want is for their child to be safe. But when that young person has a food allergy, keeping them safe becomes an even greater challenge.

It’s estimated that around 1 in 50 children have a peanut allergy, and it’s one of the most common food allergies. In fact, one study even found that almost 25% of kids could have the affliction. Going to any unfamiliar place can be a huge hurdle for people with peanut allergies. Every trip to a restaurant is fraught with danger. But a recent development could make living with this particular food allergy much simpler.

New treatment

Now, in the UK, a new oral treatment could reduce the severity of symptoms – including anaphylaxis. After an extensive two-year study, researchers found that Palforzia – the new treatment – could increase tolerance to food with peanuts in it.

The idea is to gradually decrease the sensitivity to peanuts over time. In one trial of the study, 67% of participants were able to ingest up to 600mg without any major problems. While it won’t eradicate the allergy, it means families could potentially eat out without fear of an anaphylactic shock or other life-threatening reactions.

Saving lives

Children in the UK will be some of the first in Europe to benefit from the new treatment after the NHS secured a deal for it. Up to 600 children aged 4 to 17 are expected to receive the treatment this year. Then there’ll be a further 2,000 every year after that. They’ll receive a monthly dose, building up tolerance slowly.

Professor Stephen Powis, NHS medical director, said: “It will reduce the fear and anxiety for patients and their families who may have been living with this allergy for years, and carrying around emergency medication just in case. They should be able to enjoy meals out or holidays abroad together without worrying about an allergic reaction that could land them in hospital or worse.”

“This first in Europe patient access deal is just one of a series of commercial agreements the NHS has secured for innovative treatments for patients over the past 18 months, while also treating thousands of people with COVID-19 as well as delivering the biggest and most successful vaccination programme in health history.”

It could be a huge turning point for the condition which causes huge worries in parents around the world. If you’re ever concerned about a potential peanut allergy, you can always talk to an allergy specialist. They will be able to find the right course of action for you.

To talk to one of our allergy experts, get in touch with us on 02031 433 449. You can also register as a new patient by following this link.

Copyright 2022. All Rights Reserved